J1596 – Injection, glycopyrrolate, 0.1 mg

Long description

Injection, glycopyrrolate, 0.1 mg

Short description

Inj, glycopyrrolate, 0.1 mg

Pricing indicator

51 Drugs

Medicare coverage

C Carrier judgment – coverage decided by the Medicare contractor

BETOS category

O1E Other drugs

ASC

Approved for ambulatory surgical centers

Added

January 1, 2024

Last change

January 1, 2025 – No change

Nearby J codes

• J1573 – Injection, hepatitis b immune globulin (hepagam b), intravenous, 0.5 ml
• J1574 – Injection, ganciclovir sodium (exela), not therapeutically equivalent to j1570, 500 mg
• J1575 – Injection, immune globulin/hyaluronidase, (hyqvia), 100 mg immuneglobulin
• J1576 – Injection, immune globulin (panzyga), intravenous, non-lyophilized (e.g., liquid), 500 mg
• J1577 – Injection, immune globulin (qivigy), 100 mg
• J1580 – Injection, garamycin, gentamicin, up to 80 mg
• J1590 – Injection, gatifloxacin, 10 mg
• J1595 – Injection, glatiramer acetate, 20 mg
• J1597 – Injection, glycopyrrolate (glyrx-pf), 0.1 mg
• J1598 – Injection, glycopyrrolate (fresenius kabi), not therapeutically equivalent to j1596, 0.1 mg
• J1599 – Injection, immune globulin, intravenous, non-lyophilized (e.g., liquid), not otherwise specified, 500 mg
• J1600 – Injection, gold sodium thiomalate, up to 50 mg
• J1602 – Injection, golimumab, 1 mg, for intravenous use
• J1610 – Injection, glucagon hydrochloride, per 1 mg
• J1611 – Injection, glucagon hydrochloride (fresenius kabi), not therapeutically equivalent to j1610, per 1 mg
• J1612 – Injection, glucagon (gvoke), 0.01 mg